Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Myxomatous Mitral Valve Disease Receiving Pimobendan or Benazepril: The QUEST Study

Häggström, Jens; Boswood, A.; O'Grady, Michael; Jöns, O.; Smith, S.; Swift, S.; Borgarelli, Michele; Gavaghan, Brad; Kvart, Clarence; DiFruscia, Rocky

doi:10.1111/jvim.12181

Research article - Peer-reviewed, 2013

Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Myxomatous Mitral Valve Disease Receiving Pimobendan or Benazepril: The QUEST Study

Häggström, Jens; Boswood, A.; O'Grady, Michael; Jöns, O.; Smith, S.; Swift, S.; Borgarelli, Michele; Gavaghan, Brad; Kvart, Clarence; DiFruscia, Rocky

Abstract

Conclusions and Clinical ImportancePimobendan versus benazepril resulted in similar QoL during the study, but conferred increased time before intensification of CHF treatment. Pimobendan treatment resulted in smaller heart size, higher body temperature, and less retention of free water.

Keywords

Canine; Mitral regurgitation; Mortality; Therapy

Published in

Journal of Veterinary Internal Medicine
2013, volume: 27, number: 6, pages: 1441-1451
Publisher: WILEY-BLACKWELL

Authors' information

Häggström, Jens

Swedish University of Agricultural Sciences, Department of Clinical Sciences

Boswood, A.

Royal Veterinary College

O'Grady, Michael

Jöns, O.

Boehringer Ingelheim Vetmedica GmbH

Smith, S.

Scarsdale Veterinary Hospital

Swift, S.

Northwest Surgeons

Borgarelli, Michele

Gavaghan, Brad

Kvart, Clarence

Swedish University of Agricultural Sciences, Department of Anatomy, Physiology and Biochemistry (AFB)

DiFruscia, Rocky

UKÄ Subject classification

Other Veterinary Science

Publication Identifiers

DOI: https://doi.org/10.1111/jvim.12181

URI (permanent link to this page)

https://res.slu.se/id/publ/51698